HEADER TRANSFERASE 25-FEB-22 7U30 TITLE PRMT5:MEP50 COMPLEXED WITH CYCLONUCLEOSIDE COMPOUND 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN ARGININE N-METHYLTRANSFERASE 5; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 72 KDA ICLN-BINDING PROTEIN,HISTONE-ARGININE N- COMPND 5 METHYLTRANSFERASE PRMT5,JAK-BINDING PROTEIN 1,SHK1 KINASE-BINDING COMPND 6 PROTEIN 1 HOMOLOG,SKB1HS; COMPND 7 EC: 2.1.1.320; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: METHYLOSOME PROTEIN 50; COMPND 11 CHAIN: B; COMPND 12 SYNONYM: MEP-50,ANDROGEN RECEPTOR COFACTOR P44,WD REPEAT-CONTAINING COMPND 13 PROTEIN 77,P44/MEP50; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRMT5, HRMT1L5, IBP72, JBP1, SKB1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: WDR77, MEP50, WD45, HKMT1069, NBLA10071; SOURCE 13 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS PRMT5, INHIBITOR, CYCLONUCLEOSIDE, METHYL TRANSFERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.L.PALTE REVDAT 2 18-OCT-23 7U30 1 REMARK REVDAT 1 01-JUN-22 7U30 0 JRNL AUTH S.KAWAMURA,R.L.PALTE,H.Y.KIM,J.SAURI,C.SONDEY,M.S.MANSUETO, JRNL AUTH 2 M.D.ALTMAN,M.R.MACHACEK JRNL TITL DESIGN AND SYNTHESIS OF UNPRECEDENTED 9- AND 10-MEMBERED JRNL TITL 2 CYCLONUCLEOSIDES WITH PRMT5 INHIBITORY ACTIVITY. JRNL REF BIOORG.MED.CHEM. V. 66 16820 2022 JRNL REFN ESSN 1464-3391 JRNL PMID 35594650 JRNL DOI 10.1016/J.BMC.2022.116820 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 89.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 40072 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 1994 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.62 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.99 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 802 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2933 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 767 REMARK 3 BIN R VALUE (WORKING SET) : 0.2939 REMARK 3 BIN FREE R VALUE : 0.2805 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.36 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 35 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7408 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 61 REMARK 3 SOLVENT ATOMS : 94 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 89.67 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.98360 REMARK 3 B22 (A**2) : 1.09250 REMARK 3 B33 (A**2) : -2.07610 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.410 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.462 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.230 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.481 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.235 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.923 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 7682 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 10460 ; 3.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2590 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1318 ; 3.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 7682 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 978 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 8616 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.87 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.93 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.70 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7U30 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1000263407. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.116 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40073 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 90.160 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 13.50 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.71 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.29600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 5OOP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CITRATE PH 6.0, 0.2 M REMARK 280 SODIUM ACETATE, 10-12% PEG 4000, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 52.20900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 69.37100 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 89.35200 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 52.20900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 69.37100 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 89.35200 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 52.20900 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 69.37100 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 89.35200 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 52.20900 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 69.37100 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 89.35200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38060 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 882 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -7 REMARK 465 ASP A -6 REMARK 465 TYR A -5 REMARK 465 LYS A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 ASP A -1 REMARK 465 ASP A 0 REMARK 465 LYS A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 MET A 4 REMARK 465 ALA A 5 REMARK 465 VAL A 6 REMARK 465 GLY A 7 REMARK 465 GLY A 8 REMARK 465 ALA A 9 REMARK 465 GLY A 10 REMARK 465 GLY A 11 REMARK 465 SER A 12 REMARK 465 THR B 329 REMARK 465 GLU B 330 REMARK 465 PRO B 331 REMARK 465 LEU B 332 REMARK 465 PRO B 333 REMARK 465 ALA B 334 REMARK 465 PRO B 335 REMARK 465 GLY B 336 REMARK 465 PRO B 337 REMARK 465 ALA B 338 REMARK 465 SER B 339 REMARK 465 VAL B 340 REMARK 465 THR B 341 REMARK 465 GLU B 342 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 C1 EDO A 706 O1 EDO A 706 2645 1.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 55 -52.54 -120.11 REMARK 500 SER A 234 -18.08 -48.96 REMARK 500 HIS A 272 65.88 -107.75 REMARK 500 ASN A 290 59.77 -111.19 REMARK 500 ASP A 306 17.41 57.61 REMARK 500 ASP A 330 82.10 -151.60 REMARK 500 LYS A 354 -1.00 -58.93 REMARK 500 GLU A 408 -66.19 -126.16 REMARK 500 ALA A 441 -85.54 63.54 REMARK 500 LEU A 445 31.86 74.55 REMARK 500 SER A 477 105.25 -163.99 REMARK 500 HIS A 507 -81.26 -120.16 REMARK 500 CYS A 518 -78.69 -108.80 REMARK 500 GLN A 561 -112.64 52.82 REMARK 500 TRP B 54 79.02 -108.94 REMARK 500 TRP B 54 79.02 -113.76 REMARK 500 ILE B 127 131.10 -39.54 REMARK 500 SER B 135 -36.30 -37.99 REMARK 500 ILE B 147 -8.98 77.71 REMARK 500 THR B 197 -19.89 -49.75 REMARK 500 THR B 245 38.13 39.10 REMARK 500 SER B 246 74.71 -157.65 REMARK 500 CYS B 247 125.92 -11.57 REMARK 500 CYS B 257 129.71 -35.80 REMARK 500 LEU B 308 -86.18 -74.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 510 DISTANCE = 5.89 ANGSTROMS REMARK 525 HOH B 511 DISTANCE = 6.30 ANGSTROMS REMARK 525 HOH B 512 DISTANCE = 7.60 ANGSTROMS DBREF 7U30 A 2 637 UNP O14744 ANM5_HUMAN 2 637 DBREF 7U30 B 18 342 UNP Q9BQA1 MEP50_HUMAN 18 342 SEQADV 7U30 MET A -7 UNP O14744 INITIATING METHIONINE SEQADV 7U30 ASP A -6 UNP O14744 EXPRESSION TAG SEQADV 7U30 TYR A -5 UNP O14744 EXPRESSION TAG SEQADV 7U30 LYS A -4 UNP O14744 EXPRESSION TAG SEQADV 7U30 ASP A -3 UNP O14744 EXPRESSION TAG SEQADV 7U30 ASP A -2 UNP O14744 EXPRESSION TAG SEQADV 7U30 ASP A -1 UNP O14744 EXPRESSION TAG SEQADV 7U30 ASP A 0 UNP O14744 EXPRESSION TAG SEQADV 7U30 LYS A 1 UNP O14744 EXPRESSION TAG SEQRES 1 A 645 MET ASP TYR LYS ASP ASP ASP ASP LYS ALA ALA MET ALA SEQRES 2 A 645 VAL GLY GLY ALA GLY GLY SER ARG VAL SER SER GLY ARG SEQRES 3 A 645 ASP LEU ASN CYS VAL PRO GLU ILE ALA ASP THR LEU GLY SEQRES 4 A 645 ALA VAL ALA LYS GLN GLY PHE ASP PHE LEU CYS MET PRO SEQRES 5 A 645 VAL PHE HIS PRO ARG PHE LYS ARG GLU PHE ILE GLN GLU SEQRES 6 A 645 PRO ALA LYS ASN ARG PRO GLY PRO GLN THR ARG SER ASP SEQRES 7 A 645 LEU LEU LEU SER GLY ARG ASP TRP ASN THR LEU ILE VAL SEQRES 8 A 645 GLY LYS LEU SER PRO TRP ILE ARG PRO ASP SER LYS VAL SEQRES 9 A 645 GLU LYS ILE ARG ARG ASN SER GLU ALA ALA MET LEU GLN SEQRES 10 A 645 GLU LEU ASN PHE GLY ALA TYR LEU GLY LEU PRO ALA PHE SEQRES 11 A 645 LEU LEU PRO LEU ASN GLN GLU ASP ASN THR ASN LEU ALA SEQRES 12 A 645 ARG VAL LEU THR ASN HIS ILE HIS THR GLY HIS HIS SER SEQRES 13 A 645 SER MET PHE TRP MET ARG VAL PRO LEU VAL ALA PRO GLU SEQRES 14 A 645 ASP LEU ARG ASP ASP ILE ILE GLU ASN ALA PRO THR THR SEQRES 15 A 645 HIS THR GLU GLU TYR SER GLY GLU GLU LYS THR TRP MET SEQRES 16 A 645 TRP TRP HIS ASN PHE ARG THR LEU CYS ASP TYR SER LYS SEQRES 17 A 645 ARG ILE ALA VAL ALA LEU GLU ILE GLY ALA ASP LEU PRO SEQRES 18 A 645 SER ASN HIS VAL ILE ASP ARG TRP LEU GLY GLU PRO ILE SEQRES 19 A 645 LYS ALA ALA ILE LEU PRO THR SER ILE PHE LEU THR ASN SEQRES 20 A 645 LYS LYS GLY PHE PRO VAL LEU SER LYS MET HIS GLN ARG SEQRES 21 A 645 LEU ILE PHE ARG LEU LEU LYS LEU GLU VAL GLN PHE ILE SEQRES 22 A 645 ILE THR GLY THR ASN HIS HIS SER GLU LYS GLU PHE CYS SEQRES 23 A 645 SER TYR LEU GLN TYR LEU GLU TYR LEU SER GLN ASN ARG SEQRES 24 A 645 PRO PRO PRO ASN ALA TYR GLU LEU PHE ALA LYS GLY TYR SEQRES 25 A 645 GLU ASP TYR LEU GLN SER PRO LEU GLN PRO LEU MET ASP SEQRES 26 A 645 ASN LEU GLU SER GLN THR TYR GLU VAL PHE GLU LYS ASP SEQRES 27 A 645 PRO ILE LYS TYR SER GLN TYR GLN GLN ALA ILE TYR LYS SEQRES 28 A 645 CYS LEU LEU ASP ARG VAL PRO GLU GLU GLU LYS ASP THR SEQRES 29 A 645 ASN VAL GLN VAL LEU MET VAL LEU GLY ALA GLY ARG GLY SEQRES 30 A 645 PRO LEU VAL ASN ALA SER LEU ARG ALA ALA LYS GLN ALA SEQRES 31 A 645 ASP ARG ARG ILE LYS LEU TYR ALA VAL GLU LYS ASN PRO SEQRES 32 A 645 ASN ALA VAL VAL THR LEU GLU ASN TRP GLN PHE GLU GLU SEQRES 33 A 645 TRP GLY SER GLN VAL THR VAL VAL SER SER ASP MET ARG SEQRES 34 A 645 GLU TRP VAL ALA PRO GLU LYS ALA ASP ILE ILE VAL SER SEQRES 35 A 645 GLU LEU LEU GLY SER PHE ALA ASP ASN GLU LEU SER PRO SEQRES 36 A 645 GLU CYS LEU ASP GLY ALA GLN HIS PHE LEU LYS ASP ASP SEQRES 37 A 645 GLY VAL SER ILE PRO GLY GLU TYR THR SER PHE LEU ALA SEQRES 38 A 645 PRO ILE SER SER SER LYS LEU TYR ASN GLU VAL ARG ALA SEQRES 39 A 645 CYS ARG GLU LYS ASP ARG ASP PRO GLU ALA GLN PHE GLU SEQRES 40 A 645 MET PRO TYR VAL VAL ARG LEU HIS ASN PHE HIS GLN LEU SEQRES 41 A 645 SER ALA PRO GLN PRO CYS PHE THR PHE SER HIS PRO ASN SEQRES 42 A 645 ARG ASP PRO MET ILE ASP ASN ASN ARG TYR CYS THR LEU SEQRES 43 A 645 GLU PHE PRO VAL GLU VAL ASN THR VAL LEU HIS GLY PHE SEQRES 44 A 645 ALA GLY TYR PHE GLU THR VAL LEU TYR GLN ASP ILE THR SEQRES 45 A 645 LEU SER ILE ARG PRO GLU THR HIS SER PRO GLY MET PHE SEQRES 46 A 645 SER TRP PHE PRO ILE LEU PHE PRO ILE LYS GLN PRO ILE SEQRES 47 A 645 THR VAL ARG GLU GLY GLN THR ILE CYS VAL ARG PHE TRP SEQRES 48 A 645 ARG CYS SER ASN SER LYS LYS VAL TRP TYR GLU TRP ALA SEQRES 49 A 645 VAL THR ALA PRO VAL CYS SER ALA ILE HIS ASN PRO THR SEQRES 50 A 645 GLY ARG SER TYR THR ILE GLY LEU SEQRES 1 B 325 ASN LEU PRO PRO ASN ALA PRO ALA CYS MET GLU ARG GLN SEQRES 2 B 325 LEU GLU ALA ALA ARG TYR ARG SER ASP GLY ALA LEU LEU SEQRES 3 B 325 LEU GLY ALA SER SER LEU SER GLY ARG CYS TRP ALA GLY SEQRES 4 B 325 SER LEU TRP LEU PHE LYS ASP PRO CYS ALA ALA PRO ASN SEQRES 5 B 325 GLU GLY PHE CYS SER ALA GLY VAL GLN THR GLU ALA GLY SEQRES 6 B 325 VAL ALA ASP LEU THR TRP VAL GLY GLU ARG GLY ILE LEU SEQRES 7 B 325 VAL ALA SER ASP SER GLY ALA VAL GLU LEU TRP GLU LEU SEQRES 8 B 325 ASP GLU ASN GLU THR LEU ILE VAL SER LYS PHE CYS LYS SEQRES 9 B 325 TYR GLU HIS ASP ASP ILE VAL SER THR VAL SER VAL LEU SEQRES 10 B 325 SER SER GLY THR GLN ALA VAL SER GLY SER LYS ASP ILE SEQRES 11 B 325 CYS ILE LYS VAL TRP ASP LEU ALA GLN GLN VAL VAL LEU SEQRES 12 B 325 SER SER TYR ARG ALA HIS ALA ALA GLN VAL THR CYS VAL SEQRES 13 B 325 ALA ALA SER PRO HIS LYS ASP SER VAL PHE LEU SER CYS SEQRES 14 B 325 SER GLU ASP ASN ARG ILE LEU LEU TRP ASP THR ARG CYS SEQRES 15 B 325 PRO LYS PRO ALA SER GLN ILE GLY CYS SER ALA PRO GLY SEQRES 16 B 325 TYR LEU PRO THR SER LEU ALA TRP HIS PRO GLN GLN SER SEQRES 17 B 325 GLU VAL PHE VAL PHE GLY ASP GLU ASN GLY THR VAL SER SEQRES 18 B 325 LEU VAL ASP THR LYS SER THR SER CYS VAL LEU SER SER SEQRES 19 B 325 ALA VAL HIS SER GLN CYS VAL THR GLY LEU VAL PHE SER SEQRES 20 B 325 PRO HIS SER VAL PRO PHE LEU ALA SER LEU SER GLU ASP SEQRES 21 B 325 CYS SER LEU ALA VAL LEU ASP SER SER LEU SER GLU LEU SEQRES 22 B 325 PHE ARG SER GLN ALA HIS ARG ASP PHE VAL ARG ASP ALA SEQRES 23 B 325 THR TRP SER PRO LEU ASN HIS SER LEU LEU THR THR VAL SEQRES 24 B 325 GLY TRP ASP HIS GLN VAL VAL HIS HIS VAL VAL PRO THR SEQRES 25 B 325 GLU PRO LEU PRO ALA PRO GLY PRO ALA SER VAL THR GLU HET EDO A 701 4 HET EDO A 702 4 HET EDO A 703 4 HET EDO A 704 4 HET EDO A 705 4 HET EDO A 706 4 HET LB3 A 707 29 HET EDO B 401 4 HET EDO B 402 4 HETNAM EDO 1,2-ETHANEDIOL HETNAM LB3 (9R,10R,11S,12R,13R,14R)-4-AMINO-9-(3,4- HETNAM 2 LB3 DIFLUOROPHENYL)-6,7,8,9,10,11,12,13-OCTAHYDRO-10,13- HETNAM 3 LB3 EPOXY[1,3]DIAZECINO[1,2-E]PURINE-11,12-DIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 EDO 8(C2 H6 O2) FORMUL 9 LB3 C18 H18 F2 N6 O3 FORMUL 12 HOH *94(H2 O) HELIX 1 AA1 GLU A 25 GLY A 37 1 13 HELIX 2 AA2 PRO A 58 ARG A 62 5 5 HELIX 3 AA3 SER A 69 LEU A 73 5 5 HELIX 4 AA4 SER A 74 LEU A 81 1 8 HELIX 5 AA5 VAL A 96 GLY A 118 1 23 HELIX 6 AA6 ASN A 131 HIS A 143 1 13 HELIX 7 AA7 ALA A 159 LEU A 163 5 5 HELIX 8 AA8 SER A 180 GLU A 182 5 3 HELIX 9 AA9 GLU A 183 CYS A 196 1 14 HELIX 10 AB1 SER A 214 TRP A 221 1 8 HELIX 11 AB2 SER A 234 PHE A 236 5 3 HELIX 12 AB3 SER A 247 LEU A 260 1 14 HELIX 13 AB4 PHE A 277 ASN A 290 1 14 HELIX 14 AB5 ASN A 295 LYS A 302 1 8 HELIX 15 AB6 GLU A 320 PHE A 327 1 8 HELIX 16 AB7 ASP A 330 VAL A 349 1 20 HELIX 17 AB8 PRO A 350 LYS A 354 5 5 HELIX 18 AB9 GLY A 369 ALA A 382 1 14 HELIX 19 AC1 ASN A 394 GLU A 408 1 15 HELIX 20 AC2 TRP A 409 SER A 411 5 3 HELIX 21 AC3 ALA A 441 GLU A 444 5 4 HELIX 22 AC4 LEU A 445 GLY A 452 1 8 HELIX 23 AC5 ALA A 453 HIS A 455 5 3 HELIX 24 AC6 SER A 477 ALA A 486 1 10 HELIX 25 AC7 GLU A 495 GLU A 499 5 5 HELIX 26 AC8 ARG A 568 HIS A 572 5 5 HELIX 27 AC9 ASN A 627 ARG A 631 5 5 HELIX 28 AD1 ASN B 69 CYS B 73 5 5 SHEET 1 AA1 9 SER A 16 ASP A 19 0 SHEET 2 AA1 9 PHE A 40 PRO A 44 1 O CYS A 42 N ARG A 18 SHEET 3 AA1 9 ILE A 82 LYS A 85 1 O VAL A 83 N LEU A 41 SHEET 4 AA1 9 ALA A 121 PRO A 125 1 O LEU A 123 N GLY A 84 SHEET 5 AA1 9 MET A 150 PRO A 156 1 O TRP A 152 N PHE A 122 SHEET 6 AA1 9 ILE A 202 GLU A 207 1 O GLU A 207 N VAL A 155 SHEET 7 AA1 9 ILE A 226 PRO A 232 1 O ALA A 228 N LEU A 206 SHEET 8 AA1 9 GLN A 263 THR A 267 1 O ILE A 265 N LEU A 231 SHEET 9 AA1 9 SER A 16 ASP A 19 1 N ASP A 19 O ILE A 266 SHEET 1 AA2 2 LEU A 237 THR A 238 0 SHEET 2 AA2 2 PRO A 244 VAL A 245 -1 O VAL A 245 N LEU A 237 SHEET 1 AA3 6 LEU A 308 GLN A 309 0 SHEET 2 AA3 6 TYR A 502 VAL A 504 -1 O VAL A 503 N GLN A 309 SHEET 3 AA3 6 ILE A 582 VAL A 592 -1 O LEU A 583 N TYR A 502 SHEET 4 AA3 6 THR A 546 TYR A 560 -1 N PHE A 551 O PHE A 584 SHEET 5 AA3 6 GLU A 467 SER A 476 -1 N PHE A 471 O TYR A 554 SHEET 6 AA3 6 GLN A 516 SER A 522 -1 O CYS A 518 N SER A 470 SHEET 1 AA4 4 HIS A 510 GLN A 511 0 SHEET 2 AA4 4 GLU A 467 SER A 476 -1 N SER A 476 O HIS A 510 SHEET 3 AA4 4 THR A 546 TYR A 560 -1 O TYR A 554 N PHE A 471 SHEET 4 AA4 4 ILE A 563 SER A 566 -1 O LEU A 565 N THR A 557 SHEET 1 AA5 5 VAL A 413 SER A 417 0 SHEET 2 AA5 5 ARG A 385 GLU A 392 1 N ALA A 390 O THR A 414 SHEET 3 AA5 5 VAL A 358 LEU A 364 1 N GLN A 359 O ARG A 385 SHEET 4 AA5 5 ALA A 429 VAL A 433 1 O VAL A 433 N LEU A 364 SHEET 5 AA5 5 LEU A 457 ILE A 464 1 O LYS A 458 N ALA A 429 SHEET 1 AA6 4 ARG A 534 PRO A 541 0 SHEET 2 AA6 4 THR A 597 SER A 606 -1 O ILE A 598 N PHE A 540 SHEET 3 AA6 4 LYS A 610 ALA A 619 -1 O ALA A 616 N ARG A 601 SHEET 4 AA6 4 ILE A 635 GLY A 636 -1 O ILE A 635 N VAL A 611 SHEET 1 AA7 4 GLN B 30 TYR B 36 0 SHEET 2 AA7 4 LEU B 42 SER B 47 -1 O SER B 47 N GLN B 30 SHEET 3 AA7 4 GLY B 56 PHE B 61 -1 O TRP B 59 N LEU B 44 SHEET 4 AA7 4 ALA B 75 THR B 79 -1 O ALA B 75 N LEU B 60 SHEET 1 AA8 4 VAL B 83 VAL B 89 0 SHEET 2 AA8 4 GLY B 93 SER B 98 -1 O LEU B 95 N THR B 87 SHEET 3 AA8 4 ALA B 102 LEU B 108 -1 O GLU B 104 N VAL B 96 SHEET 4 AA8 4 ILE B 115 TYR B 122 -1 O VAL B 116 N GLU B 107 SHEET 1 AA9 4 VAL B 128 VAL B 133 0 SHEET 2 AA9 4 GLN B 139 SER B 144 -1 O VAL B 141 N SER B 132 SHEET 3 AA9 4 ILE B 149 ASP B 153 -1 O TRP B 152 N ALA B 140 SHEET 4 AA9 4 VAL B 158 TYR B 163 -1 O TYR B 163 N ILE B 149 SHEET 1 AB1 4 VAL B 170 ALA B 175 0 SHEET 2 AB1 4 VAL B 182 SER B 187 -1 O LEU B 184 N ALA B 174 SHEET 3 AB1 4 ILE B 192 ASP B 196 -1 O LEU B 193 N SER B 185 SHEET 4 AB1 4 ALA B 203 ILE B 206 -1 O ILE B 206 N ILE B 192 SHEET 1 AB2 4 PRO B 215 TRP B 220 0 SHEET 2 AB2 4 VAL B 227 ASP B 232 -1 O GLY B 231 N THR B 216 SHEET 3 AB2 4 THR B 236 ASP B 241 -1 O VAL B 240 N PHE B 228 SHEET 4 AB2 4 LEU B 249 ALA B 252 -1 O LEU B 249 N LEU B 239 SHEET 1 AB3 4 LEU B 261 PHE B 263 0 SHEET 2 AB3 4 LEU B 271 SER B 273 -1 O ALA B 272 N VAL B 262 SHEET 3 AB3 4 LEU B 280 LEU B 283 -1 O ALA B 281 N SER B 273 SHEET 4 AB3 4 GLU B 289 SER B 293 -1 O LEU B 290 N VAL B 282 SHEET 1 AB4 3 VAL B 300 TRP B 305 0 SHEET 2 AB4 3 LEU B 312 GLY B 317 -1 O THR B 314 N THR B 304 SHEET 3 AB4 3 VAL B 322 VAL B 326 -1 O HIS B 325 N LEU B 313 SSBOND 1 CYS B 208 CYS B 247 1555 1555 2.04 CISPEP 1 GLU A 57 PRO A 58 0 19.54 CISPEP 2 GLY A 64 PRO A 65 0 -4.68 CISPEP 3 ILE A 464 PRO A 465 0 7.80 CISPEP 4 HIS A 523 PRO A 524 0 3.87 CISPEP 5 ALA A 619 PRO A 620 0 5.93 CISPEP 6 ALA B 67 PRO B 68 0 12.10 CRYST1 104.418 138.742 178.704 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009577 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007208 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005596 0.00000